Phase I/II study of HB-EGF-specific inhibitor BK-UM plus weekly paclitaxel therapy in gastric cancer with peritoneal metastasis after failure of first line treatment.
Phase of Trial: Phase I/II
Latest Information Update: 17 May 2016
At a glance
- Drugs CRM 197 (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer; Peritoneal cancer
- Focus Therapeutic Use
- 13 Apr 2016 Status changed from suspended to discontinued.
- 07 Dec 2015 Status changed from recruiting to suspended, as reported by University Hospital Medical Information Network - Japan.
- 19 Mar 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan